Home Tools
Log in
Cart

Search Result

Search Results for " aβ-in-2 "

20

Compounds

Cat No. Product Name Synonyms Targets
T63689 -IN-2
-IN-2 is a peptide inhibitor of 1-42. -IN-2 inhibits the in vitro self-aggregation of 1-42 by delaying the growth phase of the 1-42 index or by reducing the number of protofibrils in the steady state.
T63208L -IN-1 TFA -IN-1 TFA(2766509-32-2 Free base)
-IN-1 TFA inhibits and reverses different types of protein aggregation.
T79571 AChE/-IN-2
AChE/-IN-2 (compound 33) is a powerful, orally active acetylcholinesterase (AChE) inhibitor with an IC50 of 135 nM. It also functions as an NMDA receptor antagonist (GluN1-1b/GluN2B subunit combination) with an IC50 of...
TN1216 2-O-Acetyl-20-hydroxyecdysone 20-Hydroxyeedysone 2-acetate Beta Amyloid , Others
2-O-Acetyl-20-hydroxyecdysone is an ecdysone present in insects and terrestrial plants. 2-O-Acetyl-20-hydroxyecdysone inhibits amyloid-β42-induced cytotoxicity and is able to reduce the formation of oligomers by promo...
T77162 Donanemab
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeting a pyroglutamate amyloid beta () epitope at the N-terminus. It shows promise for research in early Alzheimer's disease [1] [2].
T22694 CRANAD 2 Others
CRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-f...
T3394 Timosaponin BII Prototimosaponin A III Beta Amyloid , Others , BACE
Timosaponin BII (Prototimosaponin A III) has anti-dementia activity and may be useful for the treatment of type 2 diabetes. Timosaponin BII has antioxidant activity, can inhibit the up-regulation of BACE1 and reduced the...
T3S0645 N-trans-Feruloyltyramine Feruloyltyramine,N-Feruloyltyramine,Moupinamide Others , COX
1. N-trans-Feruloyltyramine (Feruloyltyramine)(NTF) has hepatoprotective effect. 2. NTF has antioxidative activity against (1-42)-induced neuronal death. 3. NTF is likely to inhibit COX enzymes, thereby suppressing P-s...
T4956 Tetrahydroxystilbene-2-O-β-D-glucoside tetrahydroxyl diphenylethylene-2-o-gluco,EH-201 Others
Tetrahydroxystilbene-2-O-β-D-glucoside (EH-201) is a low MW inducer of erythropoietin. Tetrahydroxystilbene-2-O-β-D-glucoside induces expression of erythropoietin, PPAR-γ coactivator 1α (PGC-1α) and haemoglobin in astroc...
T11359 Gamma-secretase modulator 2 Others
Gamma-secretase modulator 2 is a potent, selective compound for the treatment of Alzheimer's disease, specifically designed to modulate γ-secretase activity. This modulation selectively attenuates the production of (1-...
T37369 Amyloid-β (1-8, A2V) Peptide Amyloid-β (1-8, A2V) Peptide
Amyloid-β (1-8, A2V) is a truncated form of amyloid-β () that contains a valine to alanine substitution at position 2 of the numbering convention ( A2V), which corresponds to position 673 of the amyloid precursor ...
T60691 AChE/BChE/BACE-1-IN-2
AChE/BChE/BACE-1-IN-2 (Compound 4o) exhibits remarkable antioxidant potential and considerable binding capability towards PAS-AChE. AChE/BChE/BACE-1-IN-2 is an orally active AChE, BACE-1 and BChE inhibitor with IC 50 val...
T76424 (Gly22)-Amyloid β-Protein (1-42)
(Gly22)-Amyloid β-Protein (1-42), a peptide fragment of Amyloid β-Protein (), plays a crucial role in Alzheimer's disease by forming the main component of both vascular and parenchymal amyloid deposits. The mutation fr...
T63995 BuChE-IN-2
BuChE-IN-2 is an excellent inhibitor of butylcholinesterase (BuChE), acting on BuChE (IC50: 1.28 μM) and NO (IC50: 0.67 μM). BuChE-IN-2 inhibits aggregation, ROS formation and Cu2+ chelation, exhibits proper blood-bra...
T83451 14,15-Epoxyeicosatrienoic acid 14,15-EET
14,15-Epoxyeicosatrienoic acid (14,15-EET), derived from Arachidonic acid metabolism, significantly inhibits platelet aggregation in vivo and enhances astrocytic clearance, making it relevant for Alzheimer's Disease r...
T79994 7-Deoxy-trans-dihydronarciclasine
7-Deoxy-trans-dihydronarciclasine is an alkaloid that functions as a tobacco mosaic virus (TMV) inhibitor with an IC50 of 1.80 μM and also serves as an anti-neuroinflammatory agent. This compound reduces and APP level...
T60837 AChE/BuChE-IN-2
AChE/BuChE-IN-2 (Compound 5f) can cross the BBB that is an orally active inhibitor of AChE and BuChE with IC 50 values of 0.72 μM and 0.16 μM, respectively. AChE/BuChE-IN-2 shows potent inhibition of self-induced β-amyl...
T76425 (Glu20)-Amyloid β-Protein (1-42)
(Glu20)-Amyloid β-Protein (1-42) represents a variant of amyloid β-protein () that fibrillizes more slowly. This is attributed to the Glu20 mutation, which diminishes 42's tendency to aggregate and inhibits the accum...
T64214 NXPZ-2
NXPZ-2 is an orally active Keap1-Nrf2protein-protein interaction (PPI) inhibitor (Ki: 95 nM, EC50: 120 and 170 nM). NXPZ-2 dose-dependently attenuates [1-42]-induced cognitive disturbances, enhances neuronal number and...
T72763 AChE/BuChE-IN-1
AChE/BuChE-IN-1, a selective butyrylcholinesterase (BuChE) inhibitor derived from chrysin, exhibits a potent efficacy with an IC50 of 0.48 μM against BuChE and a lesser inhibitory effect on acetylcholinesterase (AChE) wi...
1 2
TargetMol